News
-
Regulatory training for French-speaking authorities in May 2022
-
Moderna Covid-19 vaccine authorised in Switzerland for children aged 6 to 11 years
-
Covid-19 vaccines: authorised – Spikevax (previously Covid-19 Vaccine Moderna)
-
Update: Safety of Covid-19 vaccines
-
Federal Supreme Court, Decision 9C_400/2021 of 20 April 2022
-
Covid-19: Federal government expands wastewater monitoring to over 100 wastewater treatment plants
-
Federal Council increases safety of in-vitro diagnostics
-
Federal Council wants to enable research to make better use of health data
-
Diagnostic neuropsychology: Federal Council approves tariff point value
-
Technical requirements for the submission of clinical trial applications for medicinal products
-
Swissmedic Journal
-
Reports of suspected adverse reactions to COVID-19 vaccines in Switzerland
-
Covid-19 treatments: authorised – Evusheld
-
Treatment and vaccines for Covid-19 – EMA regular press briefing on Covid-19
-
Organ donation register is still blocked
-
Evaluation of Covid-19 crisis management: Recommendations to the Federal Office of Public Health
-
Federal Council requests extension of certain provisions in the Covid-19 Act
-
The Federal Council wants to further develop the electronic patient dossier
-
Covid-19: Adaptation of the Covid certificates to the EU
-
NCCS-Impacts program: upcoming call for project proposals
-
The revision of Chapters 17.1 and 17.2 of Pharmacopoea Helvetica 12